Marc Subirats is a General Partner of Nina Capital, a specialized venture capital firm investing exclusively at the intersection of healthcare and technology, with an international outlook from Nina's home in Europe.
As a General Partner, Marc focuses on working with Nina's team towards seeding need-driven founders committed to improving healthcare with the help of technology and providing strategic and operational support to Nina's portfolio founders. He does so by leveraging his track record of business leadership, which he developed as co-founder and chief executive officer of Advance Medical. Over twenty years, Marc grew the health technology company from a pitch deck to a turnover of +75 million euros with operations in 10 countries (including the US and Europe) and a global workforce of +1000 workers. Teladoc Health (NYSE listed company) acquired Advance Medical in 2018.
Marc holds an MBA from IESE Business School and an Economics degree from UAB.